Applying quantum computing
The industrialisation of quantum computing has only just begun. At QUTAC, important German companies come together to put our country and Europe at the forefront of the development of this crucial future technology.Dr. Reinhard Ploss Chairman of the QUTAC Executive Committee & former CEO Infineon Technologies AG
News
Munich Re: understanding, calculating and hedging complex risks
At Munich Re, Dr. Andreas Bayerstadler and his team are researching quantum technology applications for modern route planning. This way, they are helping to make Germany a pioneer in quantum technology – and to protect companies more intelligently against economic losses in the future.
More
BASF: How quantum computing can help develop chemical catalysts
With the help of quantum computing, BASF intends to accelerate the development of new catalysts within polymer research. To do so, it is relying on a hybrid approach - and collaboration with QUTAC.
More
“Only markets make the development of quantum solutions economically attractive.”
The industrialisation of quantum computing requires not only basic technology, but also a functioning market, says Dr. Andre Luckow, Head of the Department for New Technologies at BMW Group IT. In This interview, he explains how QUTAC intends to strengthen the development of industrial applications and hot the BMW Group, both within the consortium and beyond, is involved in the field of quantum computing.
More
"Quantum computing will become a key enabling technology"
Quantum technologies will trigger a series of disruptive innovations, says BASF Chairman of the Board Dr. Martin Brudermüller. In an interview, he explains what we can expect from this new technology, the challenges involved in its development and why now is exactly the right time to establish an industry consortium like QUTAC.
More
Boehringer Ingelheim: A question of time
For the simulation of complex molecules, Boehringer Ingelheim CTO Clemens Utschig-Utschig also considers the potential of quantum computing. This way, extensive laboratory experiments may be reduced in the future – and with them the time needed to develop new drugs.
More
